SOLENO THERAPEUTICS, INC.

Lobbying client · California · filed 2026 to 2026

Soleno is focused on development of novel therapeutics for treatment of rare diseases.

$150,000 Reported spend

3 Filings counted

1 Firms hired

4 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (72934), not by name.

Firms hired 1

SOLENO THERAPEUTICS, INC. $150,000 3 filings

Bills named in these filings 4

HR 1414
Cameron’s Law

3 filings
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

3 filings
HR 7118
Genomic Answers for Children’s Health Act of 2026

3 filings
S 832
EPIC Act of 2025

3 filings

Reported by year 1 year

2026 $150,000 3 filings

Issues lobbied 7

Economics/Economic Development 3
Financial Institutions/Investments/Securities 3
Health Issues 3
Insurance 3
Medicare/Medicaid 3
Pharmacy 3
Trade (domestic/foreign) 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 3 total

Q2

SOLENO THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $70,000 expenses · posted Jul 20, 2026

View → Q1

SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $80,000 expenses · posted May 8, 2026

View → RR

SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · posted May 4, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.